Health Technology Assessment and Health Policy Today : A Multifaceted View of their Unstable Crossroads
Material type:
Item type | Current location | Call number | URL | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Electronic Book | UT Tyler Online Online | RA393 -- .H435 2015eb (Browse shelf) | http://uttyler.eblib.com/patron/FullRecord.aspx?p=1965331 | Available | EBL1965331 |
Table of contents; Authors; Foreword; PART I: CRITICAL OVERVIEW; 1 Health Technology Assessment and its Interface with Regulation, Policy and Management; Introduction; Health Technology Assessment and Regulators ; Health Technology Assessment and Health Policy Makers; Health Technology Assessment and Health Service Managers; Conclusions; REFERENCES; 2 Health Technology Assessment (HTA) and the Incentives to Innovation in the Life Cycle of a Health Technology; Introduction; The Meaning of Innovation; What is Innovation in Health Technology?
Key Decisions in the Life Cycle of Health Technologies: Do the Present Institutional Arrangements Provide Appropriate Incentives for Socially Needed Innovation?Options and Proposals for Using Health Technology Assessment to Assist Policy Practices Aimed at Promoting Socially Needed Innovation in Health; Conclusions; Recommendations; REFERENCES; 3 The Wisdom Tooth of Health Technology Assessment; A New Old Science?; Assessing the Assessments; From Peer Review to Ceteris Paribus; The Lurker at the Threshold; REFERENCES
4 Regaining Health Technology Assessment from Oblivion: Improving and Integrating Regulation of Drugs, Medical Devices, Diagnostic Tests and Surgical InnovationsIntroduction; Medical Devices; Diagnostic Tests; Surgery; Indispensable Measures for Improving and Integrating Regulatory Reform of Drugs, Medical Devices, Diagnostic Tests and Surgical Innovations; Acknowledgements; REFERENCES; PART II: ISSUES; 5 Four Issues in Cost-Effectiveness Analysis and Health Technology Assessment: a View from the Touch-line; Introduction; Issue 1: Cost-Effectiveness Analysis - What Is It?
Issue 2: How Specific, How General?Issue 3: Quality-adjusted Life-years Versus Disability-adjusted Life-years - Can There Be a Winner?; Issue 4: Societal Perspective - Is There No Alternative?; Conclusions; Acknowledgments; REFERENCES; 6 Measuring QALYs for HTA and Health Policy Decision Making: Bridging the Gap Between Power and Act; Introduction; Quality-adjusted Life-years and Health State Utility Measurement; First Solution: Debiasing; Second Solution: Using Less Biased Methods; Discussion; Conclusions and Recommendations; REFERENCES
7 What Health Technology Assessment System Do we Really Need? A Critical Review of the Current Situation of Health Technology Assessment in Five European CountriesWhat is Health Technology Assessment?; The Current Situation of the Health Technology Assessment System in Spain; Health Technology Assessment in England/Wales, France, Germany, Sweden and Spain: Learning From One Another; Valuable Lessons on Health Technology Assessment for the European Union: Operating as a Network of National Bodies?
Foregone Benefits and Future Possibilities of Effectiveness Improvements on Health Technology Assessment Outcomes and Dissemination
This book disentangles the issues in connection with the advancement of Health Technology Assessment (HTA) and its interface with health policy. It highlights the factors that should shape its progress in the near future. Interdisciplinary and critical views from a number of professionals are put together in a prescient order to cast some light and make recommendations as to the next steps HTA should take to be fit for purpose. A wealth of documents dealing with HTA have been published over the last three decades. HTA allegedly is one of the bedrocks of regulation and medical decision making.
Description based upon print version of record.
There are no comments on this title.